GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » United Health Products Inc (OTCPK:UEEC) » Definitions » Financial Strength

United Health Products (United Health Products) Financial Strength : 4 (As of Mar. 2024)


View and export this data going back to . Start your Free Trial

What is United Health Products Financial Strength?

United Health Products has the Financial Strength Rank of 4.

GuruFocus Financial Strength Rank measures how strong a company's financial situation is. It is based on these factors:

1. The debt burden that the company has as measured by its Interest Coverage (current year). The higher, the better.
2. Debt to revenue ratio. The lower, the better.
3. Altman Z-Score.

United Health Products did not have earnings to cover the interest expense. As of today, United Health Products's Altman Z-Score is 0.00.


Competitive Comparison of United Health Products's Financial Strength

For the Medical Instruments & Supplies subindustry, United Health Products's Financial Strength, along with its competitors' market caps and Financial Strength data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


United Health Products's Financial Strength Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, United Health Products's Financial Strength distribution charts can be found below:

* The bar in red indicates where United Health Products's Financial Strength falls into.



United Health Products Financial Strength Calculation

GuruFocus Financial Strength Rank measures how strong a company's financial situation is. It is based on these factors

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

1. The debt burden that the company has as measured by its Interest Coverage (current year). The higher, the better.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:

United Health Products's Interest Expense for the months ended in Mar. 2024 was $-0.03 Mil. Its Operating Income for the months ended in Mar. 2024 was $-0.43 Mil. And its Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was $0.04 Mil.

United Health Products's Interest Coverage for the quarter that ended in Mar. 2024 is

United Health Products did not have earnings to cover the interest expense.

The higher the ratio, the stronger the company's financial strength is.

2. Debt to revenue ratio. The lower, the better.

United Health Products's Debt to Revenue Ratio for the quarter that ended in Mar. 2024 is

Debt to Revenue Ratio=Total Debt (Q: Mar. 2024 ) / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(0.738 + 0.04) / 0
=N/A

3. Altman Z-Score.

Z-Score model is an accurate forecaster of failure up to two years prior to distress. It can be considered the assessment of the distress of industrial corporations.

The zones of discrimination were as such:

When Z-Score is less than 1.81, it is in Distress Zones.
When Z-Score is greater than 2.99, it is in Safe Zones.
When Z-Score is between 1.81 and 2.99, it is in Grey Zones.

United Health Products has a Z-score of 0.00, indicating it is in Distress Zones. This implies bankrupcy possibility in the next two years.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


United Health Products  (OTCPK:UEEC) Financial Strength Explanation

The maximum rank is 10. Companies with rank 7 or higher will be unlikely to fall into distressed situations. Companies with rank of 3 or less are likely in financial distress.

United Health Products has the Financial Strength Rank of 4.


United Health Products Financial Strength Related Terms

Thank you for viewing the detailed overview of United Health Products's Financial Strength provided by GuruFocus.com. Please click on the following links to see related term pages.


United Health Products (United Health Products) Business Description

Traded in Other Exchanges
N/A
Address
526 Commerce Circle, Suite No. 120, Mesquite, NV, USA, 89027
United Health Products Inc is a US-based company. It mainly manufactures and markets a patented hemostatic gauze for the healthcare and wound care sectors. The company's product HemoStyp is derived from regenerated oxidized cellulose, which is naturally designed to absorb exudate from superficial wounds and helps control bleeding. It markets its product to dental and medical markets as well as, sports, military and veterinary sectors, and others. The company's trademarks include Boo Boo Strips; The Ultimate Bandage; Hemostrips; CelluSTAT and Nik Fix.
Executives
Brian David Thom officer: CEO 10624 S EASTERN AVE., STE A209, HENDERSON NV 89052
Kristofer Heaton officer: Vice-President Finance, CFO 526 COMMERCE CIRCLE, STE 120, MESQUITE NV 89027
Nate Knight director C/O MORSE & MORSE, PLLC, 1400 OLD COUNTRY ROAD, SUITE 302, WESTBURY NY 11590
Louis Schiliro officer: Chief Operating Officer 10624 S. EASTERN AVENUE, STE. A209, HENDERSON NV 89052
Douglas K Beplate officer: CEO
Robert J. Denser director 10624 S. EASTERN AVE., STE. A209, HENDERSON NV 89052
John Vito Capotorto director 1090 KING GEORGES POST ROAD, SUITE 501, EDISON NJ 08837
Sherman Lazrus director
Rodney Paul Leibowitz director 420 EAST 54TH STREET, APARTMENT 15B, NEW YORK NY 10022
Michael R. Wiechnik director 11 PRESWICK DR., MEDFORD NJ 08055
Richard Rifenburgh director 2637 E. ATLANTIC BLVD., #133, POMPANO BEACH FL 33062
Phillip David Forman director, officer: President, Chairman and CEO 1090 KING GEORGES POST RD,501, EDISON NJ 08837
Jan E Chason director, officer: Chief Financial Officer 120 WALL STREET, SUITE 2401, NEW YORK NY 10005
Kelly Thomas Hickel director, officer: Chief Executive Officer 1630A 30TH STREET, SUITE 300, BOULDER CO 80301
Patrick Donelan 10 percent owner 3570 LAKEVIEW DRIVE, DELRAY BEACH FL 33445